Latest News about CI
Recent news which mentions CI
3 Dirt-Cheap Health Stocks to Buy on Weakness
April 30, 2024
From InvestorPlace
Arthritis Patients - Cigna's Evernorth To Offer Humira Biosimilar At No Out-of-Pocket Cost
April 26, 2024
From Benzinga
3 Healthcare Stocks to Buy Now: Q2 Edition
April 24, 2024
From InvestorPlace
The Top 3 Healthcare Stocks to Buy in April 2024
April 22, 2024
From InvestorPlace
3 Weight-Loss ETFs to Profit From the Obesity Drug Boom
April 17, 2024
From InvestorPlace
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
April 04, 2024
From Benzinga
The 3 Best Healthcare Stocks to Buy in April 2024
April 03, 2024
From InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
April 03, 2024
From Benzinga
Why Are Health Insurance Stocks HUM, UNH, CI Down Today?
April 02, 2024
From InvestorPlace
From Motley Fool
From Benzinga
Inconsistent Insurance Coverage For Weight Loss Drugs - Novo Nordisk's GLP-1s Face Hurdles Despite Health Benefits
March 18, 2024
From Benzinga
From Benzinga
From Benzinga
Insurance Coverage For Weight Loss Drugs - Cigna Unveils Efforts To Limit Health Plans/Employers Spending
March 07, 2024
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
February 29, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 26, 2024
From Benzinga
From Benzinga
$100 Invested In Cigna Group 20 Years Ago Would Be Worth This Much Today
February 08, 2024
From Benzinga
Cigna 'Top Pick for 2024': Analysts Change Ratings, Forecasts Following 2024 Guidance
February 05, 2024
From Benzinga
From Benzinga
Cigna Analysts Increase Their Forecasts After Upbeat Earnings
February 05, 2024
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.